Broadfin Capital
Overview
Broadfin Capital is a global equity healthcare manager founded in 2005. Broadfin seeks to achieve mid-teen percent net returns through the consistent application of a value-oriented investment strateg…
Investment Focus
- Healthcare-focused companies
- Established market presence
- Strong growth potential
Portfolio Companies
Reach Broadfin Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Broadfin Capital
What sectors does Broadfin Capital invest in?
Broadfin Capital invests in Healthcare, Pharmaceuticals, Biotechnology and Medical Technology, and is based in New York, United States. Broadfin Capital is listed as a private investment firm in the ConnectSafely investor database.
What stage does Broadfin Capital invest at?
Broadfin Capital backs companies at Early Stage, Growth, Late Stage, Pre-IPO and Buyout.
Which regions does Broadfin Capital invest in?
Broadfin Capital invests across United States.
Who are the partners at Broadfin Capital?
Team members listed for Broadfin Capital include Kevin Kotler (Founder).
What companies has Broadfin Capital invested in?
Broadfin Capital's portfolio includes Intra-Cellular Therapies, Iovance Biotherapeutics and RedHill Biopharma.
How do I contact Broadfin Capital?
Broadfin Capital's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database